[{"question": "What did he do to drive a culture of innovation, change capability, and personal autonomy?", "answer": "He succeeded in a major change effort which reorganized the department and drove a culture of innovation, change capability, and personal autonomy with accountability."}, {"question": "What company was he previously working for?", "answer": "Newman previously worked for Mesoblast Inc."}, {"question": "How long has Kenneth Newman been at Ionis Pharmaceuticals?", "answer": "from Duke University, Kenneth Newman has 4 yrs 6 mos of experience as a Vice President at Ionis Pharmaceuticals, Inc."}, {"question": "What was his role at Acton Pharmaceuticals?", "answer": "Newman subsequently worked at Acton Pharmaceuticals as their Chief Medical Officer, responsible for clinical development and medical affairs."}, {"question": "What was his previous role at Mesoblast Inc.?", "answer": ", which is the leading stem cell company, as the head of global clinical development / chief development officer."}, {"question": "What is Kenneth Newman's background?", "answer": "Newman\u2019s medical training was at Duke, Johns Hopkins, and the NIH and he is triple board certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine."}, {"question": "How long has Kenneth Newman been at Ionis Pharmaceuticals?", "answer": "in, 4 yrs of experience as a Vice President at Boehringer Ingelheim in, 9 yrs of experience as a Executive Director at Forest Laboratories, Inc."}, {"question": "What was his first job at Forest Labs?", "answer": "He was initially appointed the director of the respiratory clinical development program at Forest Labs."}, {"question": "What was his role at Boehringer Ingelheim?", "answer": "Newman joined Boehringer Ingelheim as the VP of Medical Affairs."}, {"question": "Where did Kenneth Newman get his M.S.?", "answer": "from The University of Texas Health Science Center at Houston (UTHealth Houston), B."}, {"question": "How long did he stay at Forest Labs?", "answer": "Over 15 years ago he left his successful academic career in order to become a pharmaceutical executive."}, {"question": "What was his role in the development of the respiratory drug?", "answer": "Successes in that role included a successful NDA, an innovative development program for product differentiation, and several in-licensed compounds."}, {"question": "What qualifications did Kenneth Newman have?", "answer": "Lindner College of Business, from University of Colorado School of Medicine, Pulmonary Critical Care Fellowship from The Johns Hopkins University School of Medicine, Internal Medicine Residency from Duke University School of Medicine, M."}, {"question": "What was his role at Forest Labs?", "answer": "Dr."}, {"question": "How many people did he have?", "answer": "Among his administrative responsibilities was a staff of about 200 and a very substantial operating annual budget."}, {"question": "What is the name of Kenneth Newman?", "answer": "D."}, {"question": "When did he join Forest Labs?", "answer": "In 2006, Dr."}, {"question": "When was Acton acquired?", "answer": "Acton was acquired by Meda Pharmaceuticals in September, 2013 for $135 million."}, {"question": "What was the name of the author?", "answer": "\"."}, {"question": "who is a pulmonary critical care physician?", "answer": "With MBA from University of Cincinnati Carl H."}]